Bajaj Healthcare Stock Hits 52-Week Low at Rs.398.4 Amidst Sector Underperformance

Current Market Context and Stock Movement

On 9 December 2025, Bajaj Healthcare’s stock price touched Rs.398.4, the lowest level recorded in the past year. Despite this, the stock outperformed its sector by 2.14% on the day, showing a modest recovery after two consecutive days of decline. However, the share price remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward pressure over multiple time frames.

In contrast, the broader market index, the Sensex, opened 359.82 points lower and was trading at 84,544.84, down 0.66%. The Sensex remains 1.91% below its 52-week high of 86,159.02 and is positioned above its 50-day moving average, which itself is above the 200-day moving average, signalling a generally bullish trend for the benchmark index.

Performance Comparison and Historical Trends

Over the last year, Bajaj Healthcare’s stock has recorded a negative return of 8.31%, contrasting with the Sensex’s positive return of 3.74% during the same period. The stock’s 52-week high was Rs.744.9, highlighting the extent of the decline to the current low. This underperformance is consistent with the company’s trend over the past three years, where it has lagged behind the BSE500 index in each annual period.

Financial Metrics and Long-Term Growth

Bajaj Healthcare’s long-term financial indicators reveal a compound annual growth rate (CAGR) of operating profits at negative 5.62% over the last five years. This suggests a contraction in operating profitability during this period. The company’s ability to service debt is constrained, with a Debt to EBITDA ratio of 2.59 times, indicating a relatively high leverage position compared to earnings before interest, taxes, depreciation, and amortisation.

Quarterly Financial Highlights

Despite the stock’s subdued price performance, Bajaj Healthcare reported positive quarterly results in September 2025. The operating profit to interest ratio reached 4.85 times, the highest recorded, indicating improved coverage of interest expenses by operating profits. The profit after tax (PAT) for the quarter was Rs.13.50 crores, reflecting a growth rate of 77.8% compared to the previous quarter. Additionally, the profit before depreciation, interest, and taxes (PBDIT) stood at Rs.26.94 crores, also the highest quarterly figure to date.

Valuation and Return Metrics

The company’s return on capital employed (ROCE) is 8.1%, which is considered attractive within its sector. The enterprise value to capital employed ratio is 2.1, suggesting that the stock is trading at a discount relative to its peers’ historical valuations. Over the past year, while the stock price has declined by 8.31%, the company’s profits have risen by 52.1%, resulting in a price/earnings to growth (PEG) ratio of 0.8. This indicates that earnings growth has outpaced the stock price movement during this period.

Shareholding and Sector Placement

Bajaj Healthcare operates within the Pharmaceuticals & Biotechnology industry and sector. The majority shareholding is held by promoters, maintaining significant control over the company’s strategic direction. The stock’s market capitalisation grade is rated at 3, reflecting its position within the market capitalisation spectrum.

Summary of Key Factors Affecting Bajaj Healthcare’s Stock Price

The stock’s decline to a 52-week low of Rs.398.4 reflects a combination of factors including sustained underperformance relative to the benchmark indices, a negative trend in operating profit growth over the medium term, and a relatively high debt burden. While quarterly results show some improvement in profitability and interest coverage, these have not yet translated into a sustained upward movement in the share price.

Additionally, the stock’s position below all major moving averages suggests that market sentiment remains cautious. The broader market environment, with the Sensex trading near its yearly highs and above key moving averages, contrasts with Bajaj Healthcare’s weaker price performance, underscoring the stock’s relative challenges within its sector.

Investors analysing Bajaj Healthcare’s recent price action and financial metrics will note the divergence between profit growth and share price movement over the past year, as well as the company’s valuation metrics compared to peers. These factors contribute to the current market assessment of the stock’s position.

Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →